Loading...

PDCT-17 (LTBK-11). PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2(+) H3.3K27M MIDLINE GLIOMAS

OBJECTIVE: To assess within a multi-center trial the safety of H3.3K27M specific peptide vaccine in combination with poly-ICLC in HLA-A02.01(+) patients diagnosed with H3.3K27M(+) diffuse midline gliomas. METHODS: Subjects 3–21 years of age with CLIA confirmed H3.3K27 mutation status were eligible....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Mueller, Sabine, Lulla, Rishi, Goldman, Stewart, Banerjee, Anu, Chi, Susan, Whipple, Nicholas, Crawford, John, Gauvain, Karen, Nazemi, Kellie, Nazarian, Javad, Taitt, Jared, Watchmaker, Payal, Nejo, Takahide, Okada, Kaori, Butterfield, Lisa, Molinaro, Annette, Prados, Michael, Okada, Hideho
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6873621/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz219.1200
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!